Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can take Mounjaro a day late. The licensed guidance allows you to administer your missed dose up to four days (96 hours) after your scheduled injection day, then continue on your usual day the following week. Your weekly schedule stays the same; you do not restart your titration. Mounjaro is a prescription-only medicine, and any concern about timing, dose changes or missed injections is best discussed with your prescriber — the guidance here is factual and general, not a replacement for personal clinical advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you realise Mounjaro is late, you face a simple fork. If fewer than four days have passed since your scheduled day, you can take the pen now and carry on as normal next week. If more than four days have passed, the right call is to leave that dose and return to your usual schedule the following week as if nothing happened. This is the approach described in the Mounjaro patient information leaflet, which you can read in full via the Mounjaro summary of product characteristics on the eMC.
A one-day delay is firmly within the safe window. Your injection lands on Thursday when it was due Wednesday? Take it Thursday. Next Wednesday's dose stays on Wednesday. That's the whole decision tree for a single-day slip.
Life has a habit of disrupting routines. A bank holiday weekend, a Friday that ate the whole week, returning from a holiday abroad with the pen in checked luggage, these catch people off guard. One day late is genuinely the easiest scenario to handle, because the guidance is unambiguous: take it, move on, keep your usual day.
Tirzepatide, the active ingredient in Mounjaro, is designed as a once-weekly treatment with a half-life that gives it meaningful staying power in the body. A single one-day delay will not dramatically alter your blood levels or undo the progress you have made. The medicine works gradually over weeks and months, so one late dose by 24 hours sits well inside the margin built into the schedule.
The concern rises as the gap extends. If you want to understand what the guidance says when the delay stretches beyond one day, the two-day scenario and three-day scenario have their own considerations, and there is a broader overview of how many days late is acceptable for each situation.
Consistent weekly dosing does matter over a full treatment course. If you find yourself taking the injection late most weeks (payday falls awkwardly, you reorder at the last moment, the pen arrives on a Thursday when your Monday schedule is already slipping) it may be worth choosing a new weekly anchor day that actually fits your life. Your prescriber can guide that conversation. The clinical team at nume reviews every repeat order before it is dispatched, which is a natural moment to raise timing questions.
The simplest fix for most people is tying the injection to something that already happens weekly without fail: a Sunday-evening routine, a Monday-morning alarm before work, the moment a weekly shopping delivery arrives. The injection sites are abdomen, thigh or upper arm; rotating between them and noting which you used last takes less than thirty seconds.
Storage matters here too. Mounjaro pens are stored in the fridge (2–8°C). If the pen is not where you expect it (buried at the back, lent to a travel bag) that alone can cause a day's delay. Keeping it in a consistent spot in the fridge door makes the habit stick. The NHS tirzepatide medicines page covers storage alongside the full side-effect and safety picture, and is worth a read if you are earlier in your treatment.
If you have already taken your dose for the week and are wondering whether an earlier or later day might suit you better overall, the guide on how late you can take Mounjaro covers the full flexibility window, including what applies when you are right at the four-day boundary. The eligibility criteria for Mounjaro are worth revisiting if you have recently moved up a dose and want to understand the clinical context your prescriber is working from.
General guidance covers the typical scenario well. There are situations where a quick conversation with a prescriber is better than self-managing: if you are at a new dose level and unsure whether the late dose counts towards your titration timeline; if you have been unwell with gastroenteritis or severe nausea and missed the dose because of that rather than forgetting; or if this is part of a pattern rather than a one-off.
Mounjaro is a prescription-only medicine, and that classification exists because individual circumstances (your current dose, any other medicines you take, how your body has responded) all shape the right call. A prescriber reviewing your case is always more specific than any general page can be.
At a cost level, understanding what private Mounjaro treatment involves across a full titration is useful context. The weight-loss treatments overview gives a plain account of how treatment is structured and what is included in a private prescription. If you are thinking about starting or are new to the process, our free consultation is the right starting point, a GPhC-registered prescriber reads your answers the same day, not a bot.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.